- Home
- IMMX vs PVL Comparison
IMMX vs PVL Comparison
Compare IMMX & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- PVL
- Stock Information
- Founded
- IMMX 2014
- PVL 2011
- Country
- IMMX United States
- PVL United States
- Employees
- IMMX N/A
- PVL N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- PVL Oil & Gas Production
- Sector
- IMMX Health Care
- PVL Energy
- Exchange
- IMMX Nasdaq
- PVL Nasdaq
- Market Cap
- IMMX 51.1M
- PVL 52.5M
- IPO Year
- IMMX 2021
- PVL N/A
- Fundamental
- Price
- IMMX $1.38
- PVL $1.61
- Analyst Decision
- IMMX Strong Buy
- PVL
- Analyst Count
- IMMX 1
- PVL 0
- Target Price
- IMMX $7.00
- PVL N/A
- AVG Volume (30 Days)
- IMMX 148.3K
- PVL 78.2K
- Earning Date
- IMMX 11-11-2024
- PVL 01-01-0001
- Dividend Yield
- IMMX N/A
- PVL 4.09%
- EPS Growth
- IMMX N/A
- PVL N/A
- EPS
- IMMX N/A
- PVL 0.23
- Revenue
- IMMX N/A
- PVL $3,338,026.00
- Revenue This Year
- IMMX N/A
- PVL N/A
- Revenue Next Year
- IMMX $200.00
- PVL N/A
- P/E Ratio
- IMMX N/A
- PVL $7.04
- Revenue Growth
- IMMX N/A
- PVL N/A
- 52 Week Low
- IMMX $1.26
- PVL $1.03
- 52 Week High
- IMMX $7.75
- PVL $2.38
- Technical
- Relative Strength Index (RSI)
- IMMX 37.40
- PVL 47.58
- Support Level
- IMMX $1.26
- PVL $1.56
- Resistance Level
- IMMX $1.80
- PVL $1.65
- Average True Range (ATR)
- IMMX 0.16
- PVL 0.06
- MACD
- IMMX -0.00
- PVL 0.00
- Stochastic Oscillator
- IMMX 22.22
- PVL 57.69
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.